50 related articles for article (PubMed ID: 15179825)
1. [Phosphatidylcholine as the basis for artificial pulmonary surfactants: comparison of surface active properties].
Khalilov EM; Torkhovskaia TI; Zakharova TS; Kochetova MM; Zdeshnev VO
Biomed Khim; 2004; 50(2):180-6. PubMed ID: 15179825
[TBL] [Abstract][Full Text] [Related]
2. Effect of antitubercular drugs on dipalmitoylphosphatidylcholine monolayers: implications for drug loaded surfactants.
Chimote G; Banerjee R
Respir Physiol Neurobiol; 2005 Jan; 145(1):65-77. PubMed ID: 15652789
[TBL] [Abstract][Full Text] [Related]
3. Comparison of distribution characteristics of phosphatidylcholines and surfactant preparation.
Zakharova TS; Fortinskaya ES; Kochetova MM; Torkhovskaya TI; Khalilov EM
Bull Exp Biol Med; 2000 Apr; 129(4):348-9. PubMed ID: 10977915
[TBL] [Abstract][Full Text] [Related]
4. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
Holm BA; Wang Z; Egan EA; Notter RH
Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
[TBL] [Abstract][Full Text] [Related]
5. Comparison of surfactant lipids between pleural and pulmonary lining fluids.
Mills PC; Chen Y; Hills YC; Hills BA
Pulm Pharmacol Ther; 2006; 19(4):292-6. PubMed ID: 16168690
[TBL] [Abstract][Full Text] [Related]
6. [Surface-active properties of phosphatidylcholines--basis for surfactant replacement therapy].
Zakharova TS; Fortinskaia ES; Kochetova MM; Babakhanov ISh; Torkhovskaia TI; Khalilov EM
Biull Eksp Biol Med; 2000 Feb; 129(2):168-70. PubMed ID: 10732237
[No Abstract] [Full Text] [Related]
7. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin.
Bernhard W; Haagsman HP; Tschernig T; Poets CF; Postle AD; van Eijk ME; von der Hardt H
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):41-50. PubMed ID: 9224208
[TBL] [Abstract][Full Text] [Related]
8. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity.
Chimote G; Banerjee R
Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):215-23. PubMed ID: 16198543
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of the monolayer-multilayer transition in a pulmonary surfactant model: IR studies of films transferred at continuously varying surface pressures.
Mao G; Desai J; Flach CR; Mendelsohn R
Langmuir; 2008 Mar; 24(5):2025-34. PubMed ID: 18198907
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylcholine molecular species of calf lung surfactant.
Kahn MC; Anderson GJ; Anyan WR; Hall SB
Am J Physiol; 1995 Nov; 269(5 Pt 1):L567-73. PubMed ID: 7491974
[TBL] [Abstract][Full Text] [Related]
11. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
Palmblad M; Johansson J; Robertson B; Curstedt T
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
[TBL] [Abstract][Full Text] [Related]
12. How does pulmonary surfactant reduce surface tension to very low values?
Zuo YY; Possmayer F
J Appl Physiol (1985); 2007 May; 102(5):1733-4. PubMed ID: 17303712
[No Abstract] [Full Text] [Related]
13. Correlations between physical and physiological properties of various preparations of lung surfactant.
Nohara K; Berggren P; Curstedt T; Grossmann G; Nilsson R; Robertson B
Eur J Respir Dis; 1986 Nov; 69(5):321-35. PubMed ID: 3792468
[TBL] [Abstract][Full Text] [Related]
14. Lipid composition greatly affects the in vitro surface activity of lung surfactant protein mimics.
Seurynck-Servoss SL; Brown NJ; Dohm MT; Wu CW; Barron AE
Colloids Surf B Biointerfaces; 2007 May; 57(1):37-55. PubMed ID: 17287113
[TBL] [Abstract][Full Text] [Related]
15. Effects of albumin and erythrocyte membranes on spread monolayers of lung surfactant lipids.
Rachana R; Banerjee R
Colloids Surf B Biointerfaces; 2006 Jun; 50(1):9-17. PubMed ID: 16650737
[TBL] [Abstract][Full Text] [Related]
16. [Dynamic measurement of surface tension versus gas chromatography dipalmitoylphosphatidylcholine analysis of amniotic fluid; a comparison of a bedside method with a highly specialized surfactant analysis].
Heytmanek G; Eppel W; Lohninger A; Salzer H
Z Geburtshilfe Perinatol; 1990; 194(2):65-9. PubMed ID: 2343610
[TBL] [Abstract][Full Text] [Related]
17. Depth profiles of pulmonary surfactant protein B in phosphatidylcholine bilayers, studied by fluorescence and electron spin resonance spectroscopy.
Cruz A; Casals C; Plasencia I; Marsh D; Pérez-Gil J
Biochemistry; 1998 Jun; 37(26):9488-96. PubMed ID: 9649332
[TBL] [Abstract][Full Text] [Related]
18. Body mass related variations in the polar lipid fatty acyl chain composition of the mammalian lung and alveolar surfactant.
Szabó A; Mézes M; Fébel H
Acta Biol Hung; 2013 Sep; 64(3):289-304. PubMed ID: 24013891
[TBL] [Abstract][Full Text] [Related]
19. Hysteresis behavior of amphiphilic model peptide in lung lipid monolayers at the air-water interface by an IRRAS measurement.
Nakahara H; Dudek A; Nakamura Y; Lee S; Chang CH; Shibata O
Colloids Surf B Biointerfaces; 2009 Jan; 68(1):61-7. PubMed ID: 18977123
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and interfacial behavior of sulfur-containing analogs of lung surfactant dipalmitoyl phosphatidylcholine.
Chang Y; Wang Z; Notter RH; Wang Z; Qu L; Schwan AL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5983-6. PubMed ID: 15546713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
